VBI Vaccines Announces Poster Presentation at 2024 ASCO Annu

VBI Vaccines Inc. , a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the...

Related Keywords

Canada , Washington , United States , Cambridge , Cambridgeshire , United Kingdom , Israel , Massachusetts , Ottawa , Ontario , Rehovot , Hamerkaz , American , Canadian , Brii Biosciences , Prehevbrio Prehevbri , Drug Administration , Company Quarterly Reports On Form , American Society Of Clinical Oncology , Oncology Center , World Vaccine Congress Washington , Nasdaq , Vaccines Inc , Clinical Oncology , Randomized Phase , Central Nervous System Tumors , Session Time , Study Design , Track Designation , Orphan Drug Designation , Accelerated Approval , Priority Review , Drug Evaluation , Biologics Evaluation , Clinical Trial Endpoints , Cancer Drugs , Private Securities Litigation Reform Act , Nasdaq Capital Market , Annual Report , Quarterly Reports , Current Reports ,